PHASE-I STUDY ON THE SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERFERON-GAMMA AND RECOMBINANT HUMAN INTERLEUKIN-2 IN PATIENTS WITH METASTATIC SOLID TUMORS

被引：13

作者：

BAARS, JW

WAGSTAFF, J

BOVEN, E

VERMORKEN, JB

VANGROENINGEN, CJ

SCHEPER, RJ

FONK, JCM

NIJMAN, HW

FRANKS, CR

DAMSMA, O

PINEDO, HM

机构：

[1] FREE UNIV AMSTERDAM HOSP,DEPT MED ONCOL,DE BOELELAAN 1117,1007 MB AMSTERDAM,NETHERLANDS

[2] BOEHRINGER INGELHEIM BV,ALKMAAR,NETHERLANDS

[3] FREE UNIV AMSTERDAM HOSP,DEPT PATHOL,1007 MB AMSTERDAM,NETHERLANDS

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1991年 / 83卷 / 19期

关键词：

D O I：

10.1093/jnci/83.19.1408

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1408 / 1410

页数：3

共 16 条

[1]

BALKWILL FR, 1989, LANCET, V1, P1060

[2]

BASHAM TY, 1983, J IMMUNOL, V130, P1492

[3] A PHASE-II STUDY OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA [J].

DUTCHER, JP ;

CREEKMORE, S ;

WEISS, GR ;

MARGOLIN, K ;

MARKOWITZ, AB ;

ROPER, M ;

PARKINSON, D ;

CIOBANU, N ;

FISHER, RI ;

BOLDT, DH ;

DOROSHOW, JH ;

RAYNER, AA ;

HAWKINS, M ;

ATKINS, M .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :477-485

[4] A NEW REGIMEN OF INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - EFFICACY WITHOUT SIGNIFICANT TOXICITY [J].

EBERLEIN, TJ ;

SCHOOF, DD ;

JUNG, SE ;

DAVIDSON, D ;

GRAMOLINI, B ;

MCGRATH, K ;

MASSARO, A ;

WILSON, RE .

ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (12) :2571-2576

[5] METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL [J].

FISHER, RI ;

COLTMAN, CA ;

DOROSHOW, JH ;

RAYNER, AA ;

HAWKINS, MJ ;

MIER, JW ;

WIERNIK, P ;

MCMANNIS, JD ;

WEISS, GR ;

MARGOLIN, KA ;

GEMLO, BT ;

HOTH, DF ;

PARKINSON, DR ;

PAIETTA, E .

ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :518-523

[6] RECOMBINANT IMMUNE INTERFERON INCREASES IMMUNOGLOBULIN-G FC-RECEPTORS ON CULTURED HUMAN MONONUCLEAR PHAGOCYTES [J].

GUYRE, PM ;

MORGANELLI, PM ;

MILLER, R .

JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (01) :393-397

[7] THE ROLE OF A GAMMA INTERFERON-LIKE LYMPHOKINE IN THE ACTIVATION OF T-CELLS FOR EXPRESSION OF INTERLEUKIN-2 RECEPTORS [J].

JOHNSON, HM ;

FARRAR, WL .

CELLULAR IMMUNOLOGY, 1983, 75 (01) :154-159

[8]

KLEINERMAN ES, 1984, J IMMUNOL, V133, P4

[9] THE DETERMINATION OF AN IMMUNOLOGICALLY ACTIVE DOSE OF INTERFERON-GAMMA IN PATIENTS WITH MELANOMA [J].

MALUISH, AE ;

URBA, WJ ;

LONGO, DL ;

OVERTON, WR ;

COGGIN, D ;

CRISP, ER ;

WILLIAMS, R ;

SHERWIN, SA ;

GORDON, K ;

STEIS, RG .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :434-445

[10] IDENTIFICATION OF INTERFERON-GAMMA AS THE LYMPHOKINE THAT ACTIVATES HUMAN MACROPHAGE OXIDATIVE-METABOLISM AND ANTI-MICROBIAL ACTIVITY [J].

NATHAN, CF ;

MURRAY, HW ;

WIEBE, ME ;

RUBIN, BY .

JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (03) :670-689

← 1 2 →